On the afternoon of October 31, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA) met with the visiting Dr. P.Y. LAM, Director of Health of the Government of the Hong Kong Special Administrative Region, and Dr. ZIEA Tat Chi from Hospital Authority of Hong Kong. Both sides reviewed the cooperation between Chinese mainland and Hong Kong SAR in drug supervision, and exchanged ideas on cooperation in the field of standards for Chinese crude drugs.